Testing the Impact of Smartphone-based Messaging to Support Young Adult Smoking Cessation
Launched by JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH · Apr 18, 2023
Trial Information
Current as of November 12, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how messaging through smartphones can help young adults quit smoking. It compares two different methods: cognitive behavioral therapy (CBT), which helps people develop strategies to deal with cravings, and mindfulness or Acceptance and Commitment Therapy (ACT), which teaches people to accept their feelings without letting them control their actions. The trial aims to see how effective these methods are when they are delivered in real-time, especially during moments when young adults might feel tempted to smoke.
To participate in this study, you need to be between 18 and 30 years old, live in the U.S., and be an English speaker with a smartphone. You should have smoked at least 100 cigarettes in your life and currently smoke at least 3 cigarettes a day on most days. If you're planning to quit smoking in the next month, this trial might be a good fit for you. Participants will receive support through messages on their phones tailored to help them navigate challenging situations related to smoking. This could be a great opportunity to get help while you're trying to quit!
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. live in the U.S.
- • 2. read English;
- • 3. are between 18 and 30 years of age;
- • 4. own an iPhone or Android smartphone;
- • 5. have smoked ≥100 cigarettes in their lives and currently smoke at least 3 cigarettes per day on 5 or more days of the week;
- • 6. are planning to quit smoking within the next 30 days.
- Exclusion Criteria:
- • None
About Johns Hopkins Bloomberg School Of Public Health
The Johns Hopkins Bloomberg School of Public Health is a leading institution dedicated to advancing public health research and education. Renowned for its rigorous academic programs and commitment to improving global health outcomes, the School conducts innovative clinical trials that address pressing health challenges. With a focus on evidence-based practices, multidisciplinary collaboration, and community engagement, the Bloomberg School leverages its extensive resources and expertise to contribute to the development of effective public health interventions and policies. Through its research endeavors, the School aims to enhance population health and inform health policy both locally and globally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Baltimore, Maryland, United States
Patients applied
Trial Officials
Johannes Thrul, PhD
Principal Investigator
Johns Hopkins Bloomberg School of Public Health
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported